- H -

Haematoxylin, [benzyl-14C]- MC 2532
HDP-CDV, sodium salt, [cytosine-2-14C]-    (Hexadecyloxypropyl cidofovir, sodium salt, [cytosine-2-14C]-) MC 2285
Heptane, [1,2-3H]- MT 1581
Hexadecane, [1-14C]-   Discontinued MC 1463
Hexadecane, [1,2-3H]-   Discontinued MT 1624
Hexadecane, [1,2-3H]- (for use as a liquid scintillation standard)   Discontinued MT 1624S
1-Hexadecanol, [1-14C]- MC 1364
1-Hexadecanol, [1-3H]- MT 1567
Hexadecynoic acid, [1-14C]- MC 1433
Hexaflumuron, [dichlorophenyl-14C(U)]- MC 2415
Hexahydroxycolupulone, [3H]- MT 1666
1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta-γ-2-benzopyran, [3-14C]-    (HHCB, [3-14C]-) MC 2301
1,1,2,3,3,8-Hexamethyl-1,2,3,5,7,8-hexahydro-6-oxa-cyclopenta[b]Naphthalene, [3H]- MT 1746
Hexamidine, [11,16-14C]- MC 2137
Hexanoic acid, [1-14C]- MC 2478
Hexanoic acid, sodium salt, [1-14C]- MC 2555
HHCB, [3H]- MT 1746
Hippuric acid, [glycyl-1-14C]- MC 2227
D-Histidine, [2,5-3H]- MT 957
L-Histidine, [14C(U)]- MC 2427
L-Histidine, [2,5-3H]- MT 905
Homovanillic acid, [2-3H]-    Discontinued MT 1643
HPMPA M 722
HPMPA, [adenine-8-14C]- MC 2273
HPMPA, [adenine-2,8-3H]- MT 722
HPMPC M 833
HPMPC, [2-14C]- MC 446
HPMPC, [5-3H]- MT 833
Hyaluronic acid, [3H]- MT 2019
4-Hydrazinobenzoic acid, [ring-14C]- MC 2194
Hydroquinone, [ring-14C(U)]- MC 1101
2'-Hydroxyacetophenone, [ring-14C(U)]- MC 2143
6-Hydroxyaminopurine, [8-14C]- MC 2162
gamma-Hydroxybutyric acid, [2,3-3H]-    Discontinued MT 844
9-Hydroxycamptothecin, [12-3H(N)]- MT 1524
1-Hydroxychlorpropham M 1931
4'-Hydroxychlorpropham M 1932
4'-Hydroxychlorpropham-O-sulfonic acid M 1933
4'-Hydroxychlorpropham-O-sulphonic acid, [ring-14C(U)]- MC 2445
Hydroxyethylpiperidine, [carboxyl-14C]- MC 2488
2-Hydroxyflutamide, [3H]- MT 1521
N-1-(4-Hydroxy-5-hydroxymethyl-bicyclo[3.1.0]hex-2-yl) thymine, [methyl-3H(N)]- MT 1749
7-Hydroxymethotrexate  
2-Hydroxy-4-methoxybenzophenone, [benzene-14C(U)]- MC 2541
4-Hydroxy-3-methoxyphenylacetic acid, [2-3H]-    Discontinued MT 1643
5-Hydroxymethylcytosine, [1-13C, 1,3-15N2]- MG 147
5-Hydroxymethyl-2'-deoxyuridine, [3H]- MT 1781
4-Hydroxy-2(E)-nonen-1-al, [2,3-3H]-    Discontinued MT 1704
2-Hydroxyoleic acid, [9,10-3H]- MT 1881
1-[((S)-2-Hydroxy-2-oxo-1,2,4-dioxaphosphorinan-5-yl)methyl], [3H]-   (cHPMPC) MT 1713
9-(3-Hydroxy-2-phosphonyl-methoxypropyl)-adenine M 722
9-(3-Hydroxy-2-phosphonyl-methoxypropyl)-adenine, [adenine-8-14C]-    (HPMPA, [adenine-8-14C]-) MC 2273
9-(3-Hydroxy-2-phosphonyl-methoxypropyl)-adenine, [adenine-2,8-3H]- MT 722
(S)-1-[3-Hydroxy-2-(phosphonyl-methoxy)propyl]-cytosine M 833
(S)-1-[3-Hydroxy-2-(phosphonyl-methoxy)propyl]-cytosine, [cytosine-1,3-15N2, 2,4,5-13C3]- MG 145
(S)-1-[3-Hydroxy-2-(phosphonyl-methoxy)propyl]-cytosine, [cytosine-2-14C]- MC 446
(S)-1-[3-Hydroxy-2-(phosphonyl-methoxy)propyl]-cytosine, [5-3H]- MT 833
3-Hydroxypicolinic acid, [carboxy-14C]- MC 2153
4-Hydroxypyrazolo[3,4-d]-pyrimidine-4-one, [3H]- MT 653
4-Hydroxyquinoline, [benzene ring-14C]- MC 2071
Hypoxanthine, [14C(U)]- MC 167
Hypoxanthine, [8-14C]- MC 147
Hypoxanthine, [2,8-3H]- MT 700
Hypoxanthine, [8-3H]- MT 1732
Back to Top

Email: info@moravek.com Phone: 1-800-447-0100 FAX: 1-714-990-1824